Sunil Yeshvanth – Ylabs
View Detailed Executive Profile →Professional Overview
- Sunil Yeshvanth is the founder and CEO of YLabs, an organization recognized for its expertise in cytology.
- In 2016, Sunil Yeshvanth established YLabs, focusing on advancements in cytopathology.
- Prior to founding YLabs, Sunil served as a Professor of Pathology at KSHEMA in Mangalore from May 2006.
- Sunil also held the position of Professor and Cytopathology Consultant at Justice KS Hegde Charitable Hospital from May 2006 until October 2021.
- Under Sunil's leadership, YLabs has contributed significantly to the field of cytopathology by enhancing diagnostic techniques and promoting cytology education.
- Sunil has overcome challenges in establishing YLabs by fostering collaborations with medical institutions and professionals.
- YLabs has played a pivotal role in training future pathologists, exemplifying a commitment to educational excellence.
- Sunil Yeshvanth has been instrumental in reaching key milestones in cytology research and development within the medical community.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| KSHEMA, MANGALORE | Professor of pathology | May 2006 |
| Justice KS Hegde Charitable Hospital (Mangalore) | Professor and Cytopathology consultant | May 2006 – Oct 2021 |
| Ylabs | Founder & CEO at Ylabs (The Cytology expert) | Jan 2016 |
| YLabs | Cytopathologist | Founder & CEO | Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Ylabs corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Sunil Yeshvanth's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Ylabs's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)